Velsipity

Pfizer’s Velsipity gets FDA approval to challenge BMS’ Zeposia in ulcerative colitis market

Pfizer’s groundbreaking approval of its drug, Velsipity, as a once-daily oral treatment for adults suffering from moderate to severe active ...